Variable
              
 

Controls
(n=10)

Patients
(n=30)

Age(years)
               

54.22   ±  5.2
              

55.60   ±  5.5

Male / Female (%)

60 / 40

56.7/ 43.3

Smokers / non-smokers (%)

60/ 40

53.3 / 46.7

Staging (%)
Stage IIA
Stage IIB
Stage III

 

---
---
--

 

33.3
43.4
23.3

Histopathological type (%)
Squamous cell carcinoma
Adenocarcinoma
Large cell carcinoma

 

----
----
----

 

53.4
23.3
23.3

Hb, g/dl,

  12.7± 2.7 

11.2 ± 2.8

RBCs (106/mm3),

4.6 ± 3. 7

4.2 ± 3.9

WBCs(103/mm3),

6.1 ± 3.7

 13.5 ± 3.2**

Platelet (103/mm3),

233  ± 3.1    

338  ± 2.2**

ESR(1h/  2h)

5.2 ± 2.7/10.7 ±   2.2

 

77.6  ± 6.7/ 107±5.78**

Serum creatinine

1.01 ± 2.1

1.0±1.9

Liver function
AST (U/l)
ALT (U/l)

 

18.2±3.8
15.02±1. 4

 

18.88±3.4
16.09±1.8

Hb=heamoglobin, WBCs= white blood cells, ESR= Erythrocetic sedimentation rate, AST= alanine spartate, ALT= alanine transferase *= P<0.5; **=P<0.01
Table 1: Demographic and hematological characteristics of controls and NSCLC patients before treatment.